- Home
- RCUS vs TYG Comparison
RCUS vs TYG Comparison
Compare RCUS & TYG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCUS
- TYG
- Stock Information
- Founded
- RCUS 2015
- TYG 2003
- Country
- RCUS United States
- TYG United States
- Employees
- RCUS N/A
- TYG N/A
- Industry
- RCUS Biotechnology: Pharmaceutical Preparations
- TYG Investment Managers
- Sector
- RCUS Health Care
- TYG Finance
- Exchange
- RCUS Nasdaq
- TYG Nasdaq
- Market Cap
- RCUS 906.4M
- TYG 738.5M
- IPO Year
- RCUS 2018
- TYG N/A
- Fundamental
- Price
- RCUS $10.40
- TYG $43.23
- Analyst Decision
- RCUS Buy
- TYG
- Analyst Count
- RCUS 8
- TYG 0
- Target Price
- RCUS $20.71
- TYG N/A
- AVG Volume (30 Days)
- RCUS 783.0K
- TYG 66.2K
- Earning Date
- RCUS 08-06-2025
- TYG 01-01-0001
- Dividend Yield
- RCUS N/A
- TYG 10.14%
- EPS Growth
- RCUS N/A
- TYG N/A
- EPS
- RCUS N/A
- TYG 5.19
- Revenue
- RCUS $262,000,000.00
- TYG $18,090,640.00
- Revenue This Year
- RCUS N/A
- TYG N/A
- Revenue Next Year
- RCUS $28.73
- TYG N/A
- P/E Ratio
- RCUS N/A
- TYG $8.35
- Revenue Growth
- RCUS 6.07
- TYG 32.84
- 52 Week Low
- RCUS $6.50
- TYG $33.73
- 52 Week High
- RCUS $18.98
- TYG $48.76
- Technical
- Relative Strength Index (RSI)
- RCUS 63.56
- TYG 52.86
- Support Level
- RCUS $9.73
- TYG $42.85
- Resistance Level
- RCUS $10.23
- TYG $43.88
- Average True Range (ATR)
- RCUS 0.53
- TYG 0.64
- MACD
- RCUS 0.07
- TYG -0.03
- Stochastic Oscillator
- RCUS 82.11
- TYG 62.57
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About TYG Tortoise Energy Infrastructure Corporation
Tortoise Energy Infrastructure Corp seeks to provide a high level of current income to stockholders. It invests in fixed-income and dividend-paying equity securities of power and energy infrastructure companies that provide stable and defensive characteristics throughout economic cycles.